TP53 and cancer: For example, although the oncogenic TAg is not directly associated with development of human cancer, its expression at the tumor site could result in functional inactivation of the critical tumor suppressor p53 and retinoblastoma (Rb) pathways,22 leading to production of a variety of tumor-derived factors that facilitate accumulation of immunosuppressing CAFs without forming a tumor.